FDA WARNING_LETTER - Rip It Vapors - December 07, 2021

On December 2, 2021, the FDA issued a Warning Letter to Rip It Vapors, LLC, following a review of submissions and inspection records. The FDA determined that Rip It Vapors manufactures and distributes e-liquid products, which are classified as tobacco products under section 201(rr) of the FD&C Act and subject to FDA jurisdiction.

The primary violation identified is the marketing of "new tobacco products" without the required premarket authorization. Specifically, the products TOP GRADE VAPORS Tobacco Gold - 24mg 30ml, RIP IT VAPORS Blue Doom - 3mg 60ml, and TOP GRADE VAPORS King Booberry - 3mg 60ml were found to be new tobacco products not commercially marketed before February 15, 2007, and lacking FDA marketing authorization orders or exemptions.

These products are deemed adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act due to the lack of required premarket authorization and failure to provide necessary reports under section 905(j). Prohibited acts under sections 301(k) and 301(p) of the FD&C Act were cited.

Rip It Vapors, a registered manufacturer with over 2,300 listed products, is required